On May 20, 2024, Accelerate Diagnostics, Inc. closed the transaction. The company has now issued 2,716,763 units at a price of $1.73 per unit for the gross proceeds of $4,699,999.99 in the transaction. The company has issued 1,156,069 Units at a price of $1.73 per unit for gross proceeds of $2,700,000.62 in its second and final tranche closing.